Chul‐min Lee

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors

Matthew D. Hellmann, T. W. Kim, Chul‐min Lee et al. · Annals of Oncology · 2019 · 188 citations · Full text

Phase Ib Study, Solid Tumors, Medicine +7

A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors

Juneko E. Grilley‐Olson, Philippe L. Bédard, Angelica Fasolo et al. · Investigational New Drugs · 2016 · 80 citations · Full text

Medicine, Metronomic Therapy, Pharmacology +7

Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings

Chul‐min Lee, Eileen L. Yoon, Mimi Kim et al. · Hepatology · 2023 · 68 citations

Expression of HuR Is Associated With Increased Cyclooxygenase-2 Expression in Uterine Cervical Carcinoma

Sung‐Jig Lim, Hyun Jung Kim, Jung Yeon Kim et al. · International Journal of Gynecological Pathology · 2007 · 41 citations

Pathology, Gynecology, Cancer Biology +19

Prevalence of advanced hepatic fibrosis and comorbidity in metabolic dysfunction‐associated fatty liver disease in Korea

Mimi Kim, Eileen L. Yoon, Seon Cho et al. · Liver International · 2022 · 37 citations